ADVISORY PANEL VOTED 6-1 TO RECOMMEND THAT US FDA DECLINE TO APPROVE DUROLANE INJECTION

Josh SandbergAugust 19, 2009

493 Less than a minute

WASHINGTON, Aug 19 (Reuters) – A U.S. Food and Drug Administration advisory panel on Wednesday:

REJECTED DUROLANE KNEE PAIN INJECTION FROM Q-MED AND SMITH & NEPHEW

VOTED 6-1 TO RECOMMEND THAT US FDA DECLINE TO APPROVE DUROLANE INJECTION (Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com)

Josh SandbergAugust 19, 2009

493 Less than a minute

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.